Diverse Clinical Isolates of Mycobacterium tuberculosis Develop Macrophage-Induced Rifampin Tolerance

J Infect Dis. 2019 Apr 19;219(10):1554-1558. doi: 10.1093/infdis/jiy710.

Abstract

The Mycobacterium tuberculosis lineage 4 strains CDC1551 and H37Rv develop tolerance to multiple antibiotics upon macrophage residence. To determine whether macrophage-induced tolerance is a general feature of clinical M. tuberculosis isolates, we assessed macrophage-induced drug tolerance in strains from lineages 1-3, representing the other predominant M. tuberculosis strains responsible for tuberculosis globally. All 3 lineages developed isoniazid tolerance. While lineage 1, 3, and 4 strains developed rifampin tolerance, lineage 2 Beijing strains did not. Their failure to develop tolerance may be explained by their harboring of a loss-of-function mutation in the Rv1258c efflux pump that is linked to macrophage-induced rifampicin tolerance.

Keywords: Rv1258c; Beijing lineage; Tuberculosis; antibiotic tolerance; drug efflux.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • ATP-Binding Cassette Transporters / genetics
  • Antitubercular Agents / pharmacology
  • Bacterial Proteins / genetics
  • Drug Resistance, Multiple, Bacterial / genetics
  • Humans
  • Isoniazid / pharmacology
  • Loss of Function Mutation
  • Macrophages / physiology*
  • Microbial Sensitivity Tests
  • Mycobacterium tuberculosis / genetics*
  • Mycobacterium tuberculosis / isolation & purification
  • Rifampin / pharmacology*
  • THP-1 Cells
  • Tuberculosis, Multidrug-Resistant / genetics
  • Tuberculosis, Multidrug-Resistant / microbiology

Substances

  • ATP-Binding Cassette Transporters
  • Antitubercular Agents
  • Bacterial Proteins
  • Rv1258c protein, Mycobacterium tuberculosis
  • Isoniazid
  • Rifampin